Table 1 Patient background-Obese and non-obese subjects-.
From: Down-regulation of vascular GLP-1 receptor expression in human subjects with obesity
|  | Obese (n = 16) (BMI ≥ 25 kg/m2) | Non-obese (n = 24) (BMI < 25 kg/m2) | p |
|---|---|---|---|
Arterial dissection/Aneurysm/ ASO/Amputation/etc. | 11/5/0/0/0 | 9/7/6/1/1 | Â |
Diabetes/Non-diabetes | 5/11 (31.3%) | 6/17 (26.1%) | n.s. |
With hypertension | 5 (31.3%) | 7 (29.2%) | n.s. |
With ARB or ACE-I | 4 (25.0%) | 3 (12.5%) | n.s. |
With Ca-blockers | 3 (18.8%) | 4 (16.7%) | n.s. |
With dyslipidemia | 13 (81.3%) | 19 (79.2%) | n.s. |
With statin | 3 (18.8%) | 8 (33.3%) | n.s. |
With anti-coagulant drugs | 0 (0%) | 4 (16.7%) | 0.036 |
Age | 61.4 ± 16.7 | 72.1 ± 9.1 | 0.047 |
BMI (kg/m2) | 28.6 ± 2.5 | 20.7 ± 2.8 | <0.0001 |
HbA1c (%) | 5.9 ± 0.6 | 6.4 ± 1.9 | n.s. |
Fasting plasma glucose (mg/dl) | 121.2 ± 32.2 | 116.6 ± 25.0 | n.s. |
LDL cholesterol (mg/dl) | 111.1 ± 38.1 | 91.3 ± 33.0 | n.s. |
HDL cholesterol (mg/dl) | 37.1 ± 10.3 | 39.0 ± 9.0 | n.s. |
C-reactive protein (mg/dl) | 2.3 ± 1.0 | 1.9 ± 0.6 | n.s. |
